133 related articles for article (PubMed ID: 27664314)
1. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
[TBL] [Abstract][Full Text] [Related]
2. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.
Gerbaulet A; Wickenhauser C; Scholten J; Peschke K; Drube S; Horny HP; Kamradt T; Naumann R; Müller W; Krieg T; Waskow C; Hartmann K; Roers A
Blood; 2011 Feb; 117(6):2012-21. PubMed ID: 21148330
[TBL] [Abstract][Full Text] [Related]
3. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
[TBL] [Abstract][Full Text] [Related]
4. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
5. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
Umiel T; Pattengale P; Weinberg K
Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
[TBL] [Abstract][Full Text] [Related]
6. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
[TBL] [Abstract][Full Text] [Related]
7. Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia.
Hauer J; Mullighan C; Morillon E; Wang G; Bruneau J; Brousse N; Lelorc'h M; Romana S; Boudil A; Tiedau D; Kracker S; Bushmann FD; Borkhardt A; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Blood; 2011 Jul; 118(3):544-53. PubMed ID: 21622646
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW
Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789
[TBL] [Abstract][Full Text] [Related]
9. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
Pedersen M; Rönnstrand L; Sun J
Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.
Kim JM; Fang J; Rheingold S; Aplenc R; Wasserman R; Grupp SA
Cancer Res; 2002 Aug; 62(15):4212-6. PubMed ID: 12154021
[TBL] [Abstract][Full Text] [Related]
11. ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.
Wandroo F; Bell A; Darbyshire P; Pratt G; Stankovic T; Gordon J; Lawson S; Moss P
Int J Lab Hematol; 2008 Apr; 30(2):149-57. PubMed ID: 18333847
[TBL] [Abstract][Full Text] [Related]
12. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
[TBL] [Abstract][Full Text] [Related]
13. Lineage specificity of rearrangement and expression of genes encoding the T cell receptor-T3 complex and immunoglobulin heavy chain in leukemia.
Furley AJ; Chan LC; Mizutani S; Ford AM; Weilbaecher K; Pegram SM; Greaves MF
Leukemia; 1987 Sep; 1(9):644-52. PubMed ID: 3118113
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.
Glodek AM; Le Y; Dykxhoorn DM; Park SY; Mostoslavsky G; Mulligan R; Lieberman J; Beggs HE; Honczarenko M; Silberstein LE
Leukemia; 2007 Aug; 21(8):1723-32. PubMed ID: 17568820
[TBL] [Abstract][Full Text] [Related]
15. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
16. C-kit receptors in childhood malignant lymphoblastic cells.
Sykora KW; Tomeczkowski J; Reiter A
Leuk Lymphoma; 1997 Apr; 25(3-4):201-16. PubMed ID: 9168431
[TBL] [Abstract][Full Text] [Related]
17. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
[TBL] [Abstract][Full Text] [Related]
18. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
19. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
